Digest Network Come funziona
Network
/
Società
Im
Non verificato

ImmunoPrecise Antibodies Ltd.

Di cosa scriviamo

BiotecnologiaFarmaceuticaHIV, AIDS e malattie autoimmuniSaluteTecnica

52 comunicati stampa

Guarda tutti i comunicati
03/09/2025
Salute
Tecnica
HIV, AIDS e malattie autoimmuni
Biotecnologia
ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”
Fonte
ImmunoPrecise Antibodies Ltd.
Emittente
Business Wire
1.00
0
02/09/2025
Salute
HIV, AIDS e malattie autoimmuni
Scienza
Farmaceutica
Biotecnologia
Eventi
ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 27th Annual Global Investment Conference in New York
Fonte
ImmunoPrecise Antibodies Ltd.
Emittente
Business Wire
1.00
0
27/08/2025
Scienza
Tecnica
HIV, AIDS e malattie autoimmuni
Software
Biotecnologia
Farmaceutica
Salute
Industria
ImmunoPrecise Advances AI Discovered and Developed Universal Dengue Vaccine Initiative: Moves into Preclinical Antibody Generation
Fonte
ImmunoPrecise Antibodies Ltd.
Emittente
Business Wire
1.00
0
06/08/2025
Sanità
Software
Scienza
Farmaceutica
Attrezzature medico-sanitarie
Tecnica
HIV, AIDS e malattie autoimmuni
Biotecnologia
Salute
Organizzazione Aziendale
ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation
Fonte
ImmunoPrecise Antibodies Ltd.
Emittente
Business Wire
1.00
0
29/07/2025
Tecnica
Scienza
HIV, AIDS e malattie autoimmuni
Software
Biotecnologia
Salute
Farmaceutica
Web e Social Network
Telefonia e Varie
Mercato azionario
ImmunoPrecise Antibodies (IPA) Reports Full Fiscal Year 2025 Results, Record Fourth Quarter Revenue, and Record Fourth Quarter Adjusted EBITDA
Fonte
ImmunoPrecise Antibodies Ltd.
Emittente
Business Wire
1.00
0
24/07/2025
Software
Scienza
Farmaceutica
Information Technology
Attrezzature medico-sanitarie
Tecnica
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Biotecnologia
Salute
Industria
ImmunoPrecise Releases New Findings Showing LENSai™ Quickly Flags Anti-Drug-Antibody Risk—Long Before the Clinic
Fonte
ImmunoPrecise Antibodies Ltd.
Emittente
Business Wire
1.00
0
21/07/2025
Tecnica
HIV, AIDS e malattie autoimmuni
Software
Biotecnologia
Salute
Farmaceutica
Information Technology
Mercato del lavoro
ImmunoPrecise Appoints Healthcare Data Visionary Jeff Fried to Advisory Board
Fonte
ImmunoPrecise Antibodies Ltd.
Emittente
Business Wire
1.00
0
16/07/2025
Tecnica
HIV, AIDS e malattie autoimmuni
Software
Biotecnologia
Salute
Farmaceutica
Information Technology
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2025 on July 29, 2025
Fonte
ImmunoPrecise Antibodies Ltd.
Emittente
Business Wire
1.00
0
14/07/2025
Salute
HIV, AIDS e malattie autoimmuni
Tecnica
Software
Farmaceutica
Biotecnologia
ImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price Requirement
Fonte
ImmunoPrecise Antibodies Ltd.
Emittente
Business Wire
1.00
0
07/07/2025
Software
Scienza
Farmaceutica
Information Technology
Tecnica
HIV, AIDS e malattie autoimmuni
Biotecnologia
Tecnologie Varie
Salute
Mercato del lavoro
ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors
Fonte
ImmunoPrecise Antibodies Ltd.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0